Wagner Dantas

Wagner Dantas serves as an Assistant Professor in the Department of Human Physiology within the College of Arts and Sciences at the University of Oregon. His research program investigates molecular mechanisms linking mitochondrial quality control systems and redox homeostasis to skeletal muscle and cardiac function in aging and obesity-related metabolic disorders, utilizing both human clinical studies and animal models.

Dr. Dantas's primary research focuses on mitochondrial dynamics in metabolic disease pathogenesis, particularly examining proteins like Miro1 and DRP1 in insulin resistance development. His work spans skeletal muscle physiology, cardiac function, and exercise interventions in obesity, type 2 diabetes, and sarcopenic obesity. Key investigations include how mitochondrial fission/fusion imbalances contribute to metabolic dysfunction and how exercise training restores mitochondrial quality control networks. His laboratory employs molecular techniques, metabolic phenotyping, and human clinical trials to dissect redox signaling pathways in metabolic tissues.

Analysis of his 2023-2025 publications reveals a dominant research trajectory centered on mitochondrial quality control mechanisms in metabolic disease. A significant portion examines exercise-induced reversal of pathological mitochondrial dynamics in human skeletal muscle during obesity and diabetes, with particular emphasis on Miro1 regulation and DRP1 hyperactivation. His work increasingly integrates gut microbiome analysis with bariatric surgery outcomes and explores pharmacological interventions like metformin for metabolic disorders, demonstrating translational approaches from Drosophila genetics to human clinical applications.

As an Assistant Professor, Dr. Dantas mentors graduate students in the Human Physiology program and leads research supported by extramural funding, though specific grant details are not publicly enumerated. His collaborative work with institutions like Pennington Biomedical Research Center indicates active engagement in multi-center metabolic research initiatives focused on exercise physiology and mitochondrial medicine.